Bendamustine in Combination With Lenalidomide and Dexamethasone in Refractory or Relapsed Multiple Myeloma
Public ClinicalTrials.gov record NCT01042704. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase I Study of Bendamustine in Combination With Lenalidomide (CC-5013) and Dexamethasone in Patients With Refractory or Relapsed Multiple Myeloma
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to see if the combination of bendamustine, lenalidomide and dexamethasone will help people with multiple myeloma that has returned after standard treatment or has been resistant to other treatments.
Study identification
- NCT ID
- NCT01042704
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 29 participants
Conditions and interventions
Conditions
Interventions
- Bendamustine Drug
- Lenalidomide Drug
- Dexamethasone Drug
- Aspirin Drug
- Prophylaxis Drug
- Antibiotic Drug
- Biweekly Follow Up Other
- Cyclical Follow Up Other
- Restaging Other
- Post-Treatment Follow Up Other
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2008 (Type not available)
- Primary completion
- Jan 2011 (Actual)
- Completion
- Mar 2015 (Actual)
- Last update posted
- Jul 31, 2017
2008 – 2015
United States locations
- U.S. sites
- 22
- U.S. states
- 3
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Karmanos Cancer Institute | Detroit | Michigan | 48201 | — |
| UPMC Cancer Centers - Teramana Cancer Center | Steubenville | Ohio | 43952 | — |
| UPMC Cancer Centers - Beaver | Beaver | Pennsylvania | 15009 | — |
| UPMC Cancer Centers - Jefferson | Clairton | Pennsylvania | 15025 | — |
| UPMC Cancer Centers - Arnold Palmer at Mountain View | Greensburg | Pennsylvania | 15601 | — |
| UPMC Cancer Centers - Arnold Palmer at Oakbrook | Greensburg | Pennsylvania | 15601 | — |
| UPMC Cancer Centers - Indiana | Indiana | Pennsylvania | 15701 | — |
| UPMC Cancer Centers - Johnstown | Johnstown | Pennsylvania | 15901 | — |
| Hematology-Oncology Associates of UPCI | McKeesport | Pennsylvania | 15132 | — |
| Hematology/Oncology - Private Practice | McKeesport | Pennsylvania | 15132 | — |
| UPMC Cancer Centers - Monroeville | Monroeville | Pennsylvania | 15146 | — |
| UPMC Cancer Centers - Arnold Palmer at Mt. Pleasant | Mount Pleasant | Pennsylvania | 15666 | — |
| UPMC Cancer Centers - New Castle | New Castle | Pennsylvania | 16105 | — |
| UPMC Cancer Centers - St. Margaret's | Pittsburgh | Pennsylvania | 15215 | — |
| UPMC Cancer Centers - Hillman Cancer Center | Pittsburgh | Pennsylvania | 15232 | — |
| UPMC Cancer Centers - Passavant | Pittsburgh | Pennsylvania | 15237 | — |
| VA Healthcare System - 646 | Pittsburgh | Pennsylvania | 15240 | — |
| UPMC Cancer Centers - Drake | Pittsburgh | Pennsylvania | 15241 | — |
| UPMC Cancer Centers - Uniontown | Uniontown | Pennsylvania | 15401 | — |
| UPMC Cancer Centers - Washington | Washington | Pennsylvania | 15301 | — |
| UPMC Cancer Centers - North Hills | Wexford | Pennsylvania | 15090 | — |
| UPMC Cancer Centers - Windber | Windber | Pennsylvania | 15963 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01042704, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 31, 2017 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01042704 live on ClinicalTrials.gov.